Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC26H32ClN3O6S |
InChIKeyDPCJYFXLXUKVAP-MFEFFIJZSA-N |
CAS Registry1314295-24-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | 25 Jun 2013 |